New treatment option for breast cancer patients sparks hope
Published
There could soon be a new treatment option for women diagnosed with an aggressive and difficult-to-treat form of breast cancer. Scientists at the Garvan Institute are beginning clinical trials with an experimental drug that's designed to make triple negative breast cancer more responsive to chemotherapy.
Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.